Tag: stent graft

Gore’s Viabahn VBX stent graft receives US FDA approval

Gore has announced recent US Food and Drug Administration (FDA) approval of a lower profile Viabahn VBX balloon expandable endoprosthesis (VBX stent graft). "Our team...
HawkOne atherectomy

Medtronic announces first enrolment in head-to-head global randomised trial evaluating durability...

Medtronic has announced the first patient enrolment in the ADVANCE trial, a head-to-head randomised controlled trial of two leading aortic stent graft systems, the...

Endologix submits premarket approval application to FDA for Detour system

Endologix has announced the submission of a premarket approval (PMA) application requesting approval for the Detour system to the US Food and Drug Administration...
Hyperflex Balloon Catheter by Endovastec Receives Marketing Approval in Japan

Hyperflex balloon catheter by Endovastec receives marketing approval in Japan

Shanghai MicroPort Endovascular MedTech (Endovastec) recently announced that it has received registration approval from Japan Pharmaceuticals and Medical Devices Agency (PMDA) for the Hyperflex...
wrapsody first study

“Very encouraging” 12-month data from WRAPSODY FIRST study presented at CIRSE...

Twelve-month results from a first-in-human study of the Wrapsody cell-impermeable endoprosthesis (Merit Medical Systems) for the treatment of access circuit stenosis in haemodialysis patients...

TORUS SFA stent graft pivotal study granted unconditional IDE approval

PQ Bypass recently announced it has received full approval of its investigational device exemption (IDE) trial of the company’s TORUS stent graft, a novel...
Endospan Nexus

CryoLife enters into strategic distribution agreement with Endospan

According to a press release, Cryolife has entered into strategic distribution and credit facility agreements with Endospan. Under the terms of the agreement, CryoLife...
INCRAFT stent

INCRAFT device deemed safe and effective according to its five-year results

Five-year data from the INSPIRATION US investigational device exception (IDE) pivotal trial confirms favourable safety and effectiveness of the INCRAFT device. Presenting the trial...

Tackling the uncommon, but devastating, complication of infection after EVAR

 Rachel Bell (Guy’s and St Thomas’ Hospital, London, UK) describes a variety of specialist surgical options to treat infection after endovascular aneurysm repair (EVAR),...

RelayBranch early feasibility study begins enrolment

The first two patients have been successfully enrolled in the RelayBranch Early Feasibility Study. This trial will assess the safety and efficacy of the...

Horizon stent graft receives CE mark

The Horizon stent graft system, developed to treat abdominal aortic aneurysms, has received CE mark. The stent graft system is produced by Endospan, a...

US FDA approves Gore Viabahn expandable stent graft for iliac artery...

The Gore Viabahn VBX balloon expandable endoprosthesis has received US Food & Drug Administration (FDA) approval for treatment of de novo or restenotic lesions found...

Five-year results confirm “long-term safety and durability” of Endologix Ovation system

Clinical data presented at the 2016 VEITH symposium (New York City, USA) of the global Ovation Pivotal Trial has revealed positive five-year safety and...

No type Ia or III endoleaks at three years with Incraft...

Preliminary results from the INNOVATION study indicate that the device is not associated with any type Ia or type III endoleaks at three years for patients undergoing EVAR. Incraft shows a freedom from sac increase rate of 95.6%.